课题基金 / 基金详情

Studies on cellular basis of the endoplasmic reticulum-associated degradation and intracellular aggregation of misfolded proteins

Studies on cellular basis of the endoplasmic reticulum-associated degradation and intracellular aggregation of misfolded proteins
错误折叠蛋白内质网相关降解和细胞内聚集的细胞基础研究
批准号:
13680695
负责人:
TOKUNAGA Fuminori
金额:
$0.83万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002

项目摘要

项目成果

TOKUNAGA Fuminori的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The endoplasmic reticuium (ER) is known to function as a quality control machinery of nascent proteins, and various misfolded or unassembled proteins in the ER are targeted to ubiquitin/proteasome-mediated degradation after retrotranslocation to the cytosol through the Sec61 translocon. We have shown that not only proteasome inhibitors such as lactacystin and carbobenzoxy-leucyl-leucyl-leucinal (LLL), but also inhibitors of ER mannosidase I such as kifunensine and deoxyrnannojirimycin, strongly inhibit the ERAD of various misfolded proteins, suggesting that processing of N-linked oligosaccharide plays an important role on ERAD. In this study, collaborating with Dr. Yoshida in Tokyo Metropolitan Institute of Medical Science, we found that N-glycan serves as a signal for degradation by the Skpl-Cullin1-Fbx2-Rbx1 (SCF^<Fbx2>) ubiquitin ligase complex. The F-box protein Fbx2 binds specifically to proteins attached to N-inked high-mannose oligosaccharides and subsequently contributes to ubiquitination of N-glycosylated proteins. In addition, expression of the mutant Fbx2ΔF, which lacks the F-box domain that is essential for forming the SCF complex, appreciably blocks degradation of typical substrates of the ERAD pathway. Our results indicate that SCF^<Fbx2> ubiquitinates N-glycosylated proteins that are translocated from the ER to the cytosol by the quality control mechanism.
期刊论文(18)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yukiko Yoshida: "E3 ubiquitin ligase that recognizes sugar chains"Nature. 418. 438-422 (2002)
吉田由纪子:“识别糖链的E3泛素连接酶”自然。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
徳永文稔: "小胞体関連分解と品質管理ユビキチンリガーゼ"実験医学. 21・3. 365-371 (2003)
德永文志:“内质网相关降解和质量控制泛素连接酶”实验医学21・3(2003)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
徳永文稔: "廣川タンパク質化学 第7巻 制御タンパク質 インヒビター"廣川書店. 199 (2002)
德永文志:《广川蛋白质化学第 7 卷调节蛋白抑制剂》广川书店 199(2002 年)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
15
    Identification of deubiquitinases, which regulate inflammatory and immune signaling pathways, and screening for their inhibitors
    • 批准号:
      16K15210
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2016
    • 负责人:
      TOKUNAGA Fuminori
    • 依托单位:
    Screening for interactors of linear ubiquitin chain assembly complex (LUBAC), and studies on their physiological functions
    Construction and application of linear ubiquitin-specific molecular probes for anti-cancer drug screening
    • 批准号:
      25670137
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.5万
    • 财政年份:
      2013
    • 负责人:
      TOKUNAGA Fuminori
    • 依托单位:
    Construction of polyubiquitin chain specific molecular probes and their applications to histopathologic examinations.
    • 批准号:
      23657075
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.5万
    • 财政年份:
      2011
    • 负责人:
      TOKUNAGA Fuminori
    • 依托单位:
    国内基金
    海外基金
    关于唐氏综合症关键区域1(DSCR1)蛋白降解途径及功能的研究
    • 批准号:
      30771075
    • 项目类别:
      面上项目
    • 资助金额:
      35.0万元
    • 批准年份:
      2007
    • 负责人:
      孙秀莲
    • 依托单位:
    细胞内磷酸化tau蛋白降解途径的研究
    • 批准号:
      30500271
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      24.0万元
    • 批准年份:
      2005
    • 负责人:
      张家玉
    • 依托单位:
    脊髓小脑变性3型蛋白导致蛋白酶体功能障碍及其机制
    • 批准号:
      30470538
    • 项目类别:
      面上项目
    • 资助金额:
      25.0万元
    • 批准年份:
      2004
    • 负责人:
      王光辉
    • 依托单位:
    proteasome抑制剂诱导恶性增殖白血病细胞凋亡的分子机制